Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBrooklyn Clinical Research
About this trial
SWIFT-CORE-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical history, comorbidities, and current symptoms. Site staff may collect vital signs, urine drug screens, blood draws, and urine pregnancy tests. A doctor will review medical history with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians and pharmacies to determine eligibility for clinical trials.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
Participant is at least 18 years old.
Disqualifiers
Participant is pregnant, breast-feeding, or planning to become pregnant.
History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
Moderate or severe substance use disorder within 90 days prior to screen
Any condition that in the investigator's opinion makes a participant unsuitable for the study.
Trial population
In year one of the program, we anticipate 4000 participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in cardiovascular, obesity, and endocrine-related therapeutic areas will be screened for clinical appropriateness for a study trial.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Blood work
Other interventionBlood work on some participants to review eligibility for future clinical trials
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Number of participants who are interested in industry-sponsored clinical research
Number of participants who are interested in industry-sponsored clinical research in each of the following therapeutic areas: cardiovascular, obesity, and endocrine.
Time frame
5 yearsSecondary outcomes
1
Characteristics associated with patient populations interested in clinical trials
Characteristics associated with patient populations interested in clinical trials stratified by demographics and therapeutic areas
Time frame
5 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov